Venture NAV Tracker / Private company
Genetix Biotherapeutics Inc.
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Current disclosed marks
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| HTGCHercules Capital, Inc. | senior secured loanFair Value — Senior Secured | $67.1MMar 31, 2026 · source ↗ | $67.1MMar 31, 2026 · source ↗ | 100.0%Mar 31, 2026 · source ↗ | Prime + 2.45 %, Floor rate 9.45 %, 6.45 % Exit FeeMar 31, 2026 · source ↗ | Apr 1, 2029Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.